Age Range
18+
Trial Purpose
Kulolu cwaningo, ababambiqhaza abanezinhlobo eziningi zezicubu eziqinile ezithuthukile (ezingenakunqandeka kanye/noma ezimetastatic) eziqhubekele phambili ekwelashweni okujwayelekile kokunakekelwa bazophathwa nge-pembrolizumab (MK-3475).
NATIONAL TRIAL REFERENCE NUMBER
I-NCT02628067
EudraCT
2015-002067-41
EU CT Number
2022-501253-37-00
When speaking to your doctor or clinical trial representative, please have the trial reference number available.
About The Study
Trial Phase
Trial start and end dates
- Actual study start date Disemba 18, 2015
- Estimated primary completion date Meyi 4, 2027
- Estimated study completion date Meyi 4, 2027
Trial locations
Sorry, there are no locations found.